Predictors of warfarin use among Ohio Medicaid patients with new-onset nonvalvular atrial fibrillation

Archives of Internal Medicine

Volumn 163, Issue 14, 2003, Pages 1705-1710

  Johnston, Joseph A ^a,b,c,e,f   Cluxton Jr , Robert J ^d   Heaton, Pamela C ^d   Guo, Jeff J ^c,d   Moomaw, Charles J ^c   Eckman, Mark H ^b,c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Div of General Internal Medicine   (United States)

^c Inst Hlth Plcy/Hlth Serv Res   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^e ELI LILLY AND COMPANY   (United States)

^f Univ of Cincinnati Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DRUG ABUSE; DRUG EFFICACY; FALLING; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STROKE; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICAID; MIDDLE AGED; MULTIVARIATE ANALYSIS; OHIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; WARFARIN;

EID: 0041807872     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.14.1705     Document Type: Article

References (33)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285:2370-2375.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
3. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449-1457.
4. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323:1505-1511.
5. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993;342:1255-1262.
6. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet. 1989;1:175-179.
7. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation. 1991;84: 527-539.
8. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991;18:349-355.
9. Ezekowitz MD, Bridgers SL, James KE, et al, for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation [published erratum appears in N Engl J Med. 1993;328:148]. N Engl J Med. 1992;327:1406-1412.
10. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999; 131:492-501.
11. Lightowlers S, McGuire A. Cost-effectiveness of anticoagulation in nonrheumatic atrial fibrillation in the primary prevention of ischemic stroke. Stroke. 1998; 29:1827-1832.
12. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest. 2001;119(suppl):194S-206S.
13. Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation. 1998;97:1231-1233.
14. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med. 2000;160:41-46.
15. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Ann Intern Med. 1999; 131:927-934.
16. Gottlieb LK, Salem-Schatz S. Anticoagulation in atrial fibrillation: does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med. 1994; 154:1945-1953.
17. Cohen N, Almoznino-Sarafian D, Alon I, et al. Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission. Stroke. 2000;31:1217-1222.
18. Beyth RJ, Antani MR, Covinsky KE, et al. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med. 1996;11:721-728.
19. Gage BF, Boechler M, Doggette AL, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation. Stroke. 2000;31:822-827.
20. Man-Son-Hing M, Nichol G, Lau A, Laupacis A. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med. 1999;159:677-685.
21. Ohio Department of Job and Family Services. Ohio Medicaid Report. 3rd ed. Columbus: Ohio Dept of Job and Family Services; 2001. Available at: http://www .state.oh.us/odjfs/ohp/bhpp/reports/omr1999/omr1.pdf. Accessed April 1, 2003.
22. Weintraub E, Dixon L, Delahanty J, et al. Reason for medical hospitalization among adult alcohol and drug abusers. Am J Addict. 2001;10:167-177.
23. Sullivan G, Burnam A, Koegel P, Hollenberg J. Quality of life of homeless persons with mental illness: results from the course-of-homelessness study. Psychiatr Serv. 2000;51:1135-1141.
24. Hwang SW. Homelessness and health. CMAJ. 2001;164:229-233.
25. Berti LC, Zylbert S, Rolnitzky L. Comparison of health status of children using a school-based health center for comprehensive care. J Pediatr Health Care. 2001; 15:244-250.
26. Goldman LS. Comorbid medical illness in psychiatric patients. Curr Psychiatry Rep. 2000;2:256-263.
27. Merrick NJ, Houchens R, Tillisch S, Berlow B, Landon C. Quality of hospital care of children with asthma: Medicaid versus privately insured patients. J Health Care Poor Underserved. 2001;12:192-207.
28. White RH, McBurnie MA, Manolio T, et al. Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort. Am J Med. 1999; 106:165-171.
29. Gurwitz JH, Monette J, Rochon PA, Eckler MA, Avorn J. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med. 1997; 157:978-984.
30. Antani MR, Beyth RJ, Covinsky KE, et al. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation. J Gen Intern Med. 1996;11:713-720.
31. Avorn J. The prescription as final common pathway. Int J Technol Assess Health Care. 1995;11:384-390.
32. Bright RA, Avorn J, Everitt DE. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol. 1989;42:937-945.
33. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med. 1997; 127:666-674.